Evaluation of cumulative prognostic score based on fibrinogen and albumin in patients with esophageal cancer: multicenter prospective cohort study

Evaluation of cumulative prognostic score based on fibrinogen and albumin in patients with esophageal cancer: multicenter prospective cohort study - Fibrinogen and albumin score in esophageal cancer patients: prospective cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012246

Enrollment

620

Registered

2013-11-08

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Older than 20 years old 2. Histologically diagnosed as Esophageal cancer 3. Undergo treatment of esophageal cancer (Esophagectomy, Eondoscopic resection, Chemoradiotherapy) 4. No previous treatment for Esophageal cancer 5. Provide informed consent

Exclusion criteria

Exclusion criteria: 1. Diagnosed as advanced cancer in past 5 years 2. Severe liver abnormalities

Design outcomes

Primary

Measure	Time frame
Disease free survival rate, overall survival rate	—

Countries

Japan

Contacts

Public ContactHirofumi Kawakubo

Keio University School of Medicine Department of Surgery

hkawakubo@z3.keio.jp03-3353-1211

Outcome results